Related Experiment Video
Updated: Apr 25, 2026

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates
Published on: February 27, 2016
The multifunctional sorting protein PACS-2 regulates SIRT1-mediated deacetylation of p53 to modulate p21-dependent
Katelyn M Atkins1, Laura L Thomas2, Jonathan Barroso-González2
1Department of Cell and Developmental Biology, Oregon Health & Science University, Portland, OR 97239, USA.
Abstract:
SIRT1 regulates the DNA damage response by deacetylating p53, thereby repressing p53 transcriptional output. Here, we demonstrate that the sorting protein PACS-2 regulates SIRT1-mediated deacetylation of p53 to modulate the DNA damage response. PACS-2 knockdown cells failed to efficiently undergo p53-induced cell-cycle arrest in response to DNA damage. Accordingly, p53 acetylation was reduced both in PACS-2 knockdown cells and thymocytes from Pacs-2(-/-) mice, thereby blunting induction of the cyclin-dependent kinase inhibitor p21 (CDKN1A). The SIRT1 inhibitor EX-527 or SIRT1 knockdown restored p53 acetylation and p21 induction as well as p21-dependent cell-cycle arrest in PACS-2 knockdown cells. Trafficking studies revealed that cytoplasmic PACS-2 shuttled to the nucleus, where it interacted with SIRT1 and repressed SIRT1-mediated p53 deacetylation. Correspondingly, in vitro assays demonstrated that PACS-2 directly inhibited SIRT1-catalyzed p53 deacetylation. Together, these findings identify PACS-2 as an in vivo mediator of the SIRT1-p53-p21 axis that modulates the DNA damage response.
Insights
The sorting protein PACS-2 regulates the DNA damage response by controlling SIRT1
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- SIRT1 deacetylates p53, repressing its transcriptional activity during DNA damage.
- The role of protein trafficking in DNA damage response regulation is emerging.
Purpose of the Study:
- To investigate the role of sorting protein PACS-2 in the DNA damage response.
- To elucidate the mechanism by which PACS-2 modulates SIRT1-mediated p53 regulation.
Main Methods:
- PACS-2 knockdown and knockout models (Pacs-2(-/-) mice).
- Analysis of p53 acetylation and p21 (CDKN1A) induction.
- Cell-cycle arrest assays.
- SIRT1 inhibition (EX-527) and knockdown.
- Subcellular localization studies (trafficking).
- In vitro deacetylation assays.
Main Results:
- PACS-2 knockdown impaired p53-induced cell-cycle arrest and p21 induction.
- Reduced p53 acetylation was observed in PACS-2 deficient cells and mice.
- SIRT1 inhibition or knockdown rescued p53 acetylation and p21 induction in PACS-2 knockdown cells.
- PACS-2 shuttles to the nucleus and directly inhibits SIRT1-mediated p53 deacetylation.
Conclusions:
- PACS-2 is a novel regulator of the SIRT1-p53-p21 pathway.
- PACS-2 modulates the DNA damage response by controlling p53 acetylation.
- PACS-2 acts as an in vivo mediator in the DNA damage response pathway.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Inhibition of Cdk Activity
Inhibition of CDK Activity
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle

